Stericycle, Inc. (NASDAQ:SRCL) Stake Lessened by KJ Harrison & Partners Inc


The company has market cap of $8.28 million. The Firm operates in the design, development, marketing and sale of power solutions for the communications, storage and computing, consumer and industrial markets segment. It has a 56.97 P/E ratio. The Company’s principal business is the production and sales of energy-saving flow control equipment, and intelligent flow control equipment.

CKX Lands, engaged in the business of ownership and management of land. (SRCL) stake by 5.54% reported in 2017Q2 SEC filing. The Grace & White Inc holds 117,700 shares with $4.69M value, up from 109,600 last quarter. Stericycle Inc now has $5.73B valuation. About 336,584 shares traded. It has underperformed by 30.82% the S&P500. In terms of volatility, it has a beta coefficient of 0.2 and technical analysis volatility indicator called Average True Range or ATR around 1.46.

Ratings analysis reveals 100% of Monolithic Power’s analysts are positive. The lowest target is $84.0 while the high is $94.0. Utd Service Automobile Association owns 26,789 shares. MPWR was included in 3 notes of analysts from November 1, 2016. Finally, Barclays PLC reiterated an “overweight” rating and issued a $100.00 price target on shares of Stericycle in a research report on Wednesday, August 9th. The firm has “Neutral” rating by Credit Suisse given on Friday, February 26.

About 79,542 shares traded. (MPWR) has risen 53.09% since November 10, 2016 and is uptrending. It has outperformed by 10.49% the S&P500. Its up 2.14% from 37,300 shares previously. A statistical measure of the dispersion of returns (volatility) for SRCL producing salvation in Investors mouth, it has week volatility of 2.17% and for the month booked as 1.81%. The Illinois-based Oberweis Asset Management Inc has invested 1.71% in the stock. Blackrock Inc., a New York-based fund reported 229 shares. Capstone Investment Advisors Llc sold 15,671 shares as Stericycle Inc (SRCL)’s stock declined 1.87%. Therefore 33% are positive.

The analysts offering 12 month price targets for Stericycle, Inc. have a median target of $87, with a high estimate of $110 and a low estimate of $73. Jefferies Group LLC set a $108.00 target price on Stericycle and gave the stock a “buy” rating in a report on Thursday, August 3rd. The stock of Stericycle Inc (NASDAQ:SRCL) earned “Sell” rating by RBC Capital Markets on Wednesday, October 11. Imperial Capital maintained the stock with “In-Line” rating in Thursday, May 26 report. Zurcher Kantonalbank Zurich Cantonalbank now owns 202,613 shares of the business services provider’s stock valued at $15,463,000 after buying an additional 57,314 shares in the last quarter. The firm has “Hold” rating given on Thursday, August 3 by Oppenheimer.

In related news, Director Mark C. Miller sold 19,753 shares of the company’s stock in a transaction dated Monday, October 30th. The rating was maintained by Wedbush with “Neutral” on Monday, May 2. As per Friday, April 29, the company rating was downgraded by RBC Capital Markets. The company was initiated on Tuesday, March 22 by Sterne Agee CRT.

The stock decreased 0.06% or $0.04 during the last trading session, reaching $64.02. K.J. Harrison & Partners Inc’s holdings in Stericycle were worth $831,000 at the end of the most recent quarter.

Dubuque Bank & Trust Co. raised its stake in Stericycle Inc. Great Lakes Advisors Limited Liability Corporation has 14,141 shares for 0.03% of their portfolio. Moreover, Bernzott has 0.04% invested in Stericycle Inc (NASDAQ:SRCL) for 3,308 shares. Inv House Ltd Llc holds 0.17% of its portfolio in Stericycle Inc (NASDAQ:SRCL) for 16,140 shares. Hall Laurie J Trustee reported 250 shares. Champlain Invest Prtn Ltd holds 828,938 shares or 0.77% of its portfolio. Bridgewater Assoc LP owns 9,555 shares.

The stock of Stericycle Incorporated (NASDAQ:SRCL) registered a decrease of 9.36% in short interest. State Treasurer State Of Michigan holds 0.02% or 27,981 shares in its portfolio. Tudor Invest Corp Et Al has 0.02% invested in Stericycle Inc (NASDAQ:SRCL). After $-0.35 actual earnings per share reported by Aldeyra Therapeutics Inc for the previous quarter, Wall Street now forecasts 20.00% negative EPS growth.

Receive News & Ratings Via Email – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings with’s FREE daily email newsletter.


Leave A Reply